Inactivated Poliovirus Vaccine Market, Global Outlook and Forecast 2024-2030
Report ID
46831
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
86
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Inactivated Poliovirus Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Inactivated Poliovirus Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Inactivated Poliovirus Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Inactivated Poliovirus Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Inactivated Poliovirus Vaccine market presents opportunities for various stakeholders, including Public, Private. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Inactivated Poliovirus Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Inactivated Poliovirus Vaccine market was valued at US$ 649.4 million in 2023 and is projected to reach US$ 885.9 million by 2030, at a CAGR of 4.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Inactivated Poliovirus Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Inactivated Poliovirus Vaccine market.
Market Overview: The report provides a comprehensive overview of the Inactivated Poliovirus Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Human Diploid Cell, Monkey Kidney Cell), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Inactivated Poliovirus Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Inactivated Poliovirus Vaccine market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Inactivated Poliovirus Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Inactivated Poliovirus Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Inactivated Poliovirus Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Inactivated Poliovirus Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Inactivated Poliovirus Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Inactivated Poliovirus Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Inactivated Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
    Human Diploid Cell
    Monkey Kidney Cell
Market segment by Application
    Public
    Private
Global Inactivated Poliovirus Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Sanofi
    GSK
    Serum Institute (Bilthoven Biologicals)
    IMBCA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inactivated Poliovirus Vaccine, market overview.
Chapter 2: Global Inactivated Poliovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Inactivated Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inactivated Poliovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Inactivated Poliovirus Vaccine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Inactivated Poliovirus Vaccine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Inactivated Poliovirus Vaccine Overall Market Size
    2.1 Global Inactivated Poliovirus Vaccine Market Size: 2023 VS 2030
    2.2 Global Inactivated Poliovirus Vaccine Revenue, Prospects & Forecasts: 2019-2030
    2.3 Global Inactivated Poliovirus Vaccine Sales: 2019-2030
3 Company Landscape
    3.1 Top Inactivated Poliovirus Vaccine Players in Global Market
    3.2 Top Global Inactivated Poliovirus Vaccine Companies Ranked by Revenue
    3.3 Global Inactivated Poliovirus Vaccine Revenue by Companies
    3.4 Global Inactivated Poliovirus Vaccine Sales by Companies
    3.5 Global Inactivated Poliovirus Vaccine Price by Manufacturer (2019-2024)
    3.6 Top 3 and Top 5 Inactivated Poliovirus Vaccine Companies in Global Market, by Revenue in 2023
    3.7 Global Manufacturers Inactivated Poliovirus Vaccine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Inactivated Poliovirus Vaccine Players in Global Market
        3.8.1 List of Global Tier 1 Inactivated Poliovirus Vaccine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Inactivated Poliovirus Vaccine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Inactivated Poliovirus Vaccine Market Size Markets, 2023 & 2030
        4.1.2 Human Diploid Cell
        4.1.3 Monkey Kidney Cell
    4.2 By Type - Global Inactivated Poliovirus Vaccine Revenue & Forecasts
        4.2.1 By Type - Global Inactivated Poliovirus Vaccine Revenue, 2019-2024
        4.2.2 By Type - Global Inactivated Poliovirus Vaccine Revenue, 2025-2030
        4.2.3 By Type - Global Inactivated Poliovirus Vaccine Revenue Market Share, 2019-2030
    4.3 By Type - Global Inactivated Poliovirus Vaccine Sales & Forecasts
        4.3.1 By Type - Global Inactivated Poliovirus Vaccine Sales, 2019-2024
        4.3.2 By Type - Global Inactivated Poliovirus Vaccine Sales, 2025-2030
        4.3.3 By Type - Global Inactivated Poliovirus Vaccine Sales Market Share, 2019-2030
    4.4 By Type - Global Inactivated Poliovirus Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Inactivated Poliovirus Vaccine Market Size, 2023 & 2030
        5.1.2 Public
        5.1.3 Private
    5.2 By Application - Global Inactivated Poliovirus Vaccine Revenue & Forecasts
        5.2.1 By Application - Global Inactivated Poliovirus Vaccine Revenue, 2019-2024
        5.2.2 By Application - Global Inactivated Poliovirus Vaccine Revenue, 2025-2030
        5.2.3 By Application - Global Inactivated Poliovirus Vaccine Revenue Market Share, 2019-2030
    5.3 By Application - Global Inactivated Poliovirus Vaccine Sales & Forecasts
        5.3.1 By Application - Global Inactivated Poliovirus Vaccine Sales, 2019-2024
        5.3.2 By Application - Global Inactivated Poliovirus Vaccine Sales, 2025-2030
        5.3.3 By Application - Global Inactivated Poliovirus Vaccine Sales Market Share, 2019-2030
    5.4 By Application - Global Inactivated Poliovirus Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
    6.1 By Region - Global Inactivated Poliovirus Vaccine Market Size, 2023 & 2030
    6.2 By Region - Global Inactivated Poliovirus Vaccine Revenue & Forecasts
        6.2.1 By Region - Global Inactivated Poliovirus Vaccine Revenue, 2019-2024
        6.2.2 By Region - Global Inactivated Poliovirus Vaccine Revenue, 2025-2030
        6.2.3 By Region - Global Inactivated Poliovirus Vaccine Revenue Market Share, 2019-2030
    6.3 By Region - Global Inactivated Poliovirus Vaccine Sales & Forecasts
        6.3.1 By Region - Global Inactivated Poliovirus Vaccine Sales, 2019-2024
        6.3.2 By Region - Global Inactivated Poliovirus Vaccine Sales, 2025-2030
        6.3.3 By Region - Global Inactivated Poliovirus Vaccine Sales Market Share, 2019-2030
    6.4 North America
        6.4.1 By Country - North America Inactivated Poliovirus Vaccine Revenue, 2019-2030
        6.4.2 By Country - North America Inactivated Poliovirus Vaccine Sales, 2019-2030
        6.4.3 US Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.4.4 Canada Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.4.5 Mexico Inactivated Poliovirus Vaccine Market Size, 2019-2030
    6.5 Europe
        6.5.1 By Country - Europe Inactivated Poliovirus Vaccine Revenue, 2019-2030
        6.5.2 By Country - Europe Inactivated Poliovirus Vaccine Sales, 2019-2030
        6.5.3 Germany Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.4 France Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.5 U.K. Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.6 Italy Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.7 Russia Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.8 Nordic Countries Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.5.9 Benelux Inactivated Poliovirus Vaccine Market Size, 2019-2030
    6.6 Asia
        6.6.1 By Region - Asia Inactivated Poliovirus Vaccine Revenue, 2019-2030
        6.6.2 By Region - Asia Inactivated Poliovirus Vaccine Sales, 2019-2030
        6.6.3 China Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.6.4 Japan Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.6.5 South Korea Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.6.6 Southeast Asia Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.6.7 India Inactivated Poliovirus Vaccine Market Size, 2019-2030
    6.7 South America
        6.7.1 By Country - South America Inactivated Poliovirus Vaccine Revenue, 2019-2030
        6.7.2 By Country - South America Inactivated Poliovirus Vaccine Sales, 2019-2030
        6.7.3 Brazil Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.7.4 Argentina Inactivated Poliovirus Vaccine Market Size, 2019-2030
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Inactivated Poliovirus Vaccine Revenue, 2019-2030
        6.8.2 By Country - Middle East & Africa Inactivated Poliovirus Vaccine Sales, 2019-2030
        6.8.3 Turkey Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.8.4 Israel Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.8.5 Saudi Arabia Inactivated Poliovirus Vaccine Market Size, 2019-2030
        6.8.6 UAE Inactivated Poliovirus Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Inactivated Poliovirus Vaccine Major Product Offerings
        7.1.4 Sanofi Inactivated Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 GSK
        7.2.1 GSK Company Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Inactivated Poliovirus Vaccine Major Product Offerings
        7.2.4 GSK Inactivated Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.2.5 GSK Key News & Latest Developments
    7.3 Serum Institute (Bilthoven Biologicals)
        7.3.1 Serum Institute (Bilthoven Biologicals) Company Summary
        7.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
        7.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Major Product Offerings
        7.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.3.5 Serum Institute (Bilthoven Biologicals) Key News & Latest Developments
    7.4 IMBCA
        7.4.1 IMBCA Company Summary
        7.4.2 IMBCA Business Overview
        7.4.3 IMBCA Inactivated Poliovirus Vaccine Major Product Offerings
        7.4.4 IMBCA Inactivated Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.4.5 IMBCA Key News & Latest Developments
8 Global Inactivated Poliovirus Vaccine Production Capacity, Analysis
    8.1 Global Inactivated Poliovirus Vaccine Production Capacity, 2019-2030
    8.2 Inactivated Poliovirus Vaccine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Inactivated Poliovirus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Inactivated Poliovirus Vaccine Supply Chain Analysis
    10.1 Inactivated Poliovirus Vaccine Industry Value Chain
    10.2 Inactivated Poliovirus Vaccine Upstream Market
    10.3 Inactivated Poliovirus Vaccine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Inactivated Poliovirus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us